Evidence map›Paper›PMID 26911712›Full record

ArticleVirology journal2016

Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.

Behzad Hajarizadeh, François Mj Lamoury, Jordan J Feld, Janaki Amin, Elizabeth Keoshkerian, Gail V Matthews, Margaret Hellard, Gregory J Dore, Andrew R Lloyd, Jason Grebely and 2 more

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Biomarkers in Detection of Hepatitis C Virus Infection.Pathogens (Basel, Switzerland) · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Behzad HajarizadehThe Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney, 2052, Australia. bhajarizadeh@kirby.unsw.edu.au.
François Mj LamouryThe Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney, 2052, Australia. flamoury@kirby.unsw.edu.au.
Jordan J FeldToronto Centre for Liver Disease, McLaughlin-Rotman Centre for Global Health, University of Toronto, Toronto, Canada. Jordan.Feld@uhn.ca.
Janaki AminThe Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney, 2052, Australia. jamin@kirby.unsw.edu.au.
Elizabeth KeoshkerianInflammation and Infection Research Centre, School of Medical Sciences, UNSW Australia, Sydney, Australia. e.keoshkerian@unsw.edu.au.
Gail V MatthewsThe Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney, 2052, Australia. gmatthews@kirby.unsw.edu.au.
Margaret HellardBurnet Institute, Melbourne, Australia. hellard@burnet.edu.au.
Gregory J DoreThe Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney, 2052, Australia. gdore@kirby.unsw.edu.au.
Andrew R LloydInflammation and Infection Research Centre, School of Medical Sciences, UNSW Australia, Sydney, Australia. a.lloyd@unsw.edu.au.
Jason GrebelyThe Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney, 2052, Australia. jgrebely@kirby.unsw.edu.au.
Tanya L ApplegateThe Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney, 2052, Australia. tapplegate@kirby.unsw.edu.au.
ATAHC Study Group
Burnet Institute · AUCentre for Inflammation Research · GBData61 · AUUNSW Sydney · AUAustralian Hearing · AUCentre for Global Health Research · CAUniversity of Toronto · CA

Funding

Treatment of recently acquired hepatitis C virus infectionR01DA015999 · NIDA · UNIVERSITY OF NEW SOUTH WALES · PI DORE, GREGORY JOHN · 2003 to 2014
$3.7M
NIDA NIH HHS R01 DA015999NIDA NIH HHS R01 DA 15999-01
6 · The paper itself

Abstract

backgroundThis study assessed the association of alanine-aminotransferase (ALT) and hepatitis C virus (HCV) RNA levels with pro-inflammatory and pro-fibrogenic cytokines and chemokines during acute HCV infection to provide further insight into the potential HCV immunopathogenesis.

methodsParticipants in the ATAHC study, a prospective study of recent HCV infection, with detectable HCV RNA at the time of HCV detection were included. Plasma levels of 27 cytokines and chemokines were measured and their correlation with ALT and HCV RNA levels were assessed. Log10 transformed cytokines and ALT values were used in the analysis.

resultsAmong 117 individuals, the plasma levels of interferon-gamma inducible protein-10 (IP-10) and macrophage inflammatory protein-1beta (MIP-1β) were positively correlated with ALT levels (IP-10: r = 0.42, P < 0.001; MIP-1β: r = 0.29, P = 0.001) and HCV RNA levels (IP-10: rs = 0.44, P < 0.001; MIP-1β: rs = 0.43, P < 0.001). Using linear regression, after adjusting for sex, age, infection duration, symptomatic infection, HIV co-infection, interferon-lambda rs12979860 genotype, HCV genotype, and assay run, higher ALT levels (β = 0.20; 95 % CI: 0.07, 0.32; P = 0.002) and HCV RNA levels >400,000 IU/mL (vs. <8,500 IU/mL; β = 0.16; 95 % CI: 0.03, 0.28; P = 0.014) were independently associated with higher IP-10 levels. HCV RNA levels >400,000 IU/mL (vs. <8,500 IU/mL; β = 0.16; 95 % CI: 0.01, 0.31; P = 0.036) were associated with higher MIP-1β levels.

conclusionsDuring acute HCV infection, high ALT and HCV RNA levels were associated with increased IP-10 levels, while high HCV RNA levels were also associated with increased MIP-1β levels. These data suggest that IP-10 and MIP-1β may have a role in HCV immuno-pathogenesis starting early in acute HCV infection.

Indexed as

Viral LoadAcute DiseaseAdultAlanine TransaminaseBiomarkersChemokinesCoinfectionCytokinesFemaleGenotypeHepacivirusHepatitis CHIV InfectionsHumansInflammation MediatorsMaleAlanine TransaminaseBiomarkersChemokinesCytokinesInflammation Mediators

Identifiers

PMID26911712
PMCPMC4765111
OpenAlexW2287987146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.